BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,985,416 | +0.2% | 132,099 | +21.0% | 0.01% | -11.1% |
| Q2 2023 | $4,975,516 | +7.3% | 109,208 | -4.5% | 0.01% | +12.5% |
| Q1 2023 | $4,636,536 | -73.3% | 114,313 | -66.4% | 0.01% | -76.5% |
| Q4 2022 | $17,355,030 | -46.3% | 340,495 | -43.3% | 0.03% | -48.5% |
| Q3 2022 | $32,344,000 | -30.8% | 600,510 | -17.4% | 0.07% | +50.0% |
| Q2 2022 | $46,724,000 | -20.2% | 727,427 | -3.7% | 0.04% | 0.0% |
| Q1 2022 | $58,568,000 | -25.8% | 755,315 | -17.8% | 0.04% | -20.0% |
| Q4 2021 | $78,913,000 | +230.9% | 919,304 | +210.0% | 0.06% | +189.5% |
| Q3 2021 | $23,848,000 | -13.9% | 296,502 | -13.9% | 0.02% | -20.8% |
| Q2 2021 | $27,706,000 | -6.5% | 344,180 | -2.0% | 0.02% | -17.2% |
| Q1 2021 | $29,618,000 | -12.4% | 351,161 | -16.7% | 0.03% | -12.1% |
| Q4 2020 | $33,825,000 | +19.3% | 421,548 | +19.6% | 0.03% | 0.0% |
| Q3 2020 | $28,342,000 | -31.4% | 352,426 | -26.5% | 0.03% | -31.2% |
| Q2 2020 | $41,303,000 | -30.5% | 479,717 | -34.4% | 0.05% | -40.0% |
| Q1 2020 | $59,407,000 | -22.0% | 731,703 | -19.7% | 0.08% | +14.3% |
| Q4 2019 | $76,176,000 | -8.5% | 910,976 | -4.3% | 0.07% | -14.6% |
| Q3 2019 | $83,274,000 | +4.3% | 952,029 | -2.4% | 0.08% | +10.8% |
| Q2 2019 | $79,867,000 | -58.8% | 975,173 | -59.1% | 0.07% | -61.5% |
| Q1 2019 | $193,925,000 | -16.2% | 2,385,005 | -32.2% | 0.19% | -24.4% |
| Q4 2018 | $231,545,000 | -27.2% | 3,518,119 | -14.7% | 0.25% | -12.1% |
| Q3 2018 | $318,024,000 | +1.1% | 4,125,366 | -3.1% | 0.29% | -5.6% |
| Q2 2018 | $314,448,000 | +2.3% | 4,258,517 | -9.9% | 0.31% | +4.1% |
| Q1 2018 | $307,453,000 | -2.4% | 4,727,132 | -3.0% | 0.29% | +18.1% |
| Q4 2017 | $315,069,000 | -1.0% | 4,874,201 | -3.8% | 0.25% | -9.8% |
| Q3 2017 | $318,092,000 | +7.1% | 5,069,197 | +3.1% | 0.28% | -3.8% |
| Q2 2017 | $297,116,000 | +33.5% | 4,915,323 | +14.6% | 0.29% | +31.7% |
| Q1 2017 | $222,496,000 | +36.7% | 4,290,315 | +16.9% | 0.22% | +49.3% |
| Q4 2016 | $162,734,000 | +12.9% | 3,670,138 | +20.7% | 0.15% | +3.5% |
| Q3 2016 | $144,118,000 | +60.7% | 3,041,856 | +53.4% | 0.14% | +46.9% |
| Q2 2016 | $89,694,000 | +15.9% | 1,983,492 | +5.3% | 0.10% | +9.1% |
| Q1 2016 | $77,389,000 | +40.3% | 1,883,875 | +30.2% | 0.09% | +41.9% |
| Q4 2015 | $55,178,000 | +13.5% | 1,446,361 | -2.2% | 0.06% | +6.9% |
| Q3 2015 | $48,595,000 | -77.3% | 1,479,285 | -73.6% | 0.06% | -74.7% |
| Q2 2015 | $214,187,000 | -72.1% | 5,599,903 | -49.9% | 0.23% | -73.8% |
| Q1 2015 | $766,407,000 | -10.3% | 11,188,420 | -4.0% | 0.88% | -7.8% |
| Q4 2014 | $854,082,000 | +88.2% | 11,653,449 | +84.3% | 0.95% | +73.5% |
| Q3 2014 | $453,876,000 | +3.4% | 6,324,039 | +4.1% | 0.55% | -0.7% |
| Q2 2014 | $439,078,000 | -0.7% | 6,073,007 | +1.0% | 0.55% | +3.6% |
| Q1 2014 | $442,245,000 | +170.9% | 6,010,412 | +156.1% | 0.53% | +155.8% |
| Q4 2013 | $163,236,000 | +313.9% | 2,347,035 | +290.9% | 0.21% | +300.0% |
| Q3 2013 | $39,441,000 | +27.0% | 600,422 | +33.9% | 0.05% | +18.2% |
| Q2 2013 | $31,068,000 | – | 448,505 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |